Simplex Trading
APTO

Simplex Trading’s Aptose Biosciences, Inc. APTO Stock Holding History

Simplex Trading’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-41
Closed -$10K – 10907
2022
Q3 		$10K Buy
41
+22
+116% +$7.58K ﹤0.01% 8285
2022
Q2 		$6K Buy
19
+1
+6% +$478 ﹤0.01% 8775
2022
Q1 		$10K Buy
+18
New +$9.95K ﹤0.01% 8924
2021
Q4 		– Sell
-35
Closed -$53K – 11762
2021
Q3 		$53K Buy
35
+1
+3% +$1.25K ﹤0.01% 7458
2021
Q2 		$51K Buy
34
+32
+1,600% +$69.7K ﹤0.01% 7631
2021
Q1 		$527K Buy
+2
New +$3.96K ﹤0.01% 3303
2020
Q2 		– Sell
-1
Closed -$368K – 8611
2020
Q1 		$368K Hold
1
– – ﹤0.01% 2925
2019
Q4 		$250K Hold
1
– – ﹤0.01% 3514
2019
Q3 		$76K Hold
1
– – ﹤0.01% 4621
2019
Q2 		$65K Buy
+1
New +$920 ﹤0.01% 4625

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Simplex Trading's APTO Position: Q4 2022 in Review

Simplex Trading sold out of Aptose Biosciences, Inc. (APTO) in Q4 2022, closing a stake of 10 shares — an estimated $2.69K sold.

Simplex Trading first reported a position in APTO in Q4 2018 and held it in 15 quarters. The position peaked at $423K in Q1 2021. 47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

  • Simplex Trading reported no remaining Aptose Biosciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 10 Aptose Biosciences, Inc. shares in Q4 2022, an estimated $2.69K.
  • Simplex Trading first reported a position in Aptose Biosciences, Inc. in Q4 2018 and held it in 15 quarters.
  • Simplex Trading's Aptose Biosciences, Inc. position peaked at $423K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.